Mika Derynck

Director/Board Member at ENLIVEN THERAPEUTICS, INC.

Net worth: - $ as of 30/04/2024

61 year

Health Technology

Consumer Services

Profile

Mika Kakefuda Derynck is currently working as a Director and Independent Director at Enliven Therapeutics, Inc. and as the Chief Medical Officer at Amunix Pharmaceuticals, Inc. She completed her undergraduate degree at Boston University and her doctorate at Boston University School of Medicine.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ENLIVEN THERAPEUTICS, INC. -.--%	08/04/2024	0 ( -.--% )	- $	30/04/2024

Mika Derynck active positions

Companies	Position	Start
ENLIVEN THERAPEUTICS, INC.	Director/Board Member	23/02/2023
Enliven Therapeutics, Inc. /US/ Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA.	Director/Board Member	19/01/2022
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA.	Chief Tech/Sci/R&D Officer	-

All active positions of Mika Derynck

Training of Mika Derynck

Boston University	Undergraduate Degree
Boston University School of Medicine	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mika Derynck's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ENLIVEN THERAPEUTICS, INC.	Health Technology

Private companies	2
Enliven Therapeutics, Inc. /US/ Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA.	Health Technology
Amunix Pharmaceuticals, Inc. Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA.	Health Technology